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Background: When rhesus monkeys (Macaca mulatta) are used to test malaria vaccines, animals are often
challenged by the intravenous injection of sporozoites. However, natural exposure to malaria comes via mosquito
bite, and antibodies can neutralize sporozoites as they traverse the skin. Thus, intravenous injection may not fairly
assess humoral immunity from anti-sporozoite malaria vaccines. To better assess malaria vaccines in rhesus, a
method to challenge large numbers of monkeys by mosquito bite was developed.
Methods: Several species and strains of mosquitoes were tested for their ability to produce Plasmodium knowlesi
sporozoites. Donor monkey parasitaemia effects on oocyst and sporozoite numbers and mosquito mortality were
documented. Methylparaben added to mosquito feed was tested to improve mosquito survival. To determine the
number of bites needed to infect a monkey, animals were exposed to various numbers of P. knowlesi-infected
mosquitoes. Finally, P. knowlesi-infected mosquitoes were used to challenge 17 monkeys in a malaria vaccine trial,
and the effect of number of infectious bites on monkey parasitaemia was documented.
Results: Anopheles dirus, Anopheles crascens, and Anopheles dirus X (a cross between the two species) produced
large numbers of P. knowlesi sporozoites. Mosquito survival to day 14, when sporozoites fill the salivary glands,
averaged only 32% when donor monkeys had a parasitaemia above 2%. However, when donor monkey
parasitaemia was below 2%, mosquitoes survived twice as well and contained ample sporozoites in their salivary
glands. Adding methylparaben to sugar solutions did not improve survival of infected mosquitoes. Plasmodium
knowlesi was very infectious, with all monkeys developing blood stage infections if one or more infected
mosquitoes successfully fed. There was also a dose-response, with monkeys that received higher numbers of
infected mosquito bites developing malaria sooner.
Conclusions: Anopheles dirus, An. crascens and a cross between these two species all were excellent vectors for
P. knowlesi. High donor monkey parasitaemia was associated with poor mosquito survival. A single infected
mosquito bite is likely sufficient to infect a monkey with P. knowlesi. It is possible to efficiently challenge large
groups of monkeys by mosquito bite, which will be useful for P. knowlesi vaccine studies.
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In 1931, Plasmodium knowlesi was identified as an infec-
tion of monkeys [1], and the following year it was experi-
mentally transmitted to humans [2]. The first naturally
occurring case of P. knowlesi in humans was reported in
1965 [3]. In 2004, it was discovered that P. knowlesi fre-
quently infects humans in Southeast Asia [4], a finding
which required PCR to distinguish P. knowlesi from
Plasmodium malariae.
Plasmodium knowlesi infections in rhesus monkeys
have been used as a model system to test malaria vaccines
[5-24]. The advantages of this model system are that the
immune systems of rhesus monkeys and humans are simi-
lar, and that P. knowlesi sporozoites are extremely infec-
tious. Often, monkeys are challenged with malaria by the
intravenous (iv) inoculation of P. knowlesi sporozoites
dissected from infected mosquitoes. Intravenous delivery
of sporozoites to monkeys is quick, and 40 monkeys can
be injected in two hours. Intravenous delivery also allows
control of sporozoite doses. In vaccine trials at our labora-
tory challenge with 100 P. knowlesi sporozoites has been
routine. With this dose, 56/56 control monkeys in 12
separate experiments (10 published [5-9] and two unpub-
lished) have all developed blood stage infections (esti-
mated probability of infection 100%, 95% CI 93.6%, 100%).
In one of these trials, 80% of vaccinated monkeys were
protected against malaria, showing that this dose of sporo-
zoites is not large enough to overwhelm the immune
response. Because of the high infectivity, only several
thousand sporozoites are needed to challenge the 30-40
monkeys in a vaccine trial. As P. knowlesi produces many
thousands of sporozoites per mosquito, few mosquitoes
are required to produce the sporozoites needed on the day
of challenge.
However, the authors are now convinced that for testing
of some malaria vaccines, challenge of monkeys should be
by mosquito bite. Vanderberg et al. [25-29] and others
[30-34] have shown how malaria sporozoites are deposited
into the skin, blood, and other tissues during probing.
They have also shown that antibodies can trap sporozoites
in the skin, preventing them from reaching the liver. Intra-
venous injection of sporozoites bypasses the barrier of the
skin, and might underestimate the effect of vaccines based
on antibodies that neutralize sporozoites [28]. Not all
malaria vaccines produce antibodies to sporozoites. Some
vaccines, such as DNA plasmid vaccines, produce few or
no antibodies in monkeys or humans, and seem to induce
only T cell immune responses. Other vaccines contain an-
tigens expressed in malaria blood or liver stages but not in
the sporozoite. Intravenous challenge may be a reasonable
method for testing such vaccines. However, many malaria
sporozoites inoculated by mosquito bite end up in the
skin or draining lymph nodes and not in the blood
stream [31,35]. It is theoretically possible that the immuneresponses to these lymphatic sporozoites might increase
or decrease vaccine responses against malaria antigens of
any parasite stage. Plasmodium knowlesi liver stages last
only 4.5 days [1], so it is unlikely that vaccine responses
would be altered by lymphatic sporozoites in time to affect
intra-hepatic immune responses. In contrast, P. knowlesi
blood stages can persist for weeks or months, and immune
responses to lymphatic sporozoites could conceivably alter
blood stage immunity and have consequences for vaccine
efficacy.
The goal of these studies was to develop a P. knowlesi
challenge model for rhesus monkeys using the bite of
infected mosquitoes. While monkeys have been infected
with P. knowlesi by mosquito bite for biologic studies,
mosquito bite challenge has never been used for testing
P. knowlesi malaria vaccines. Theoretically, the malaria
exposure of monkeys in a vaccine trial should be adequate
to show a statistically significant difference in infection
between the control and vaccinated group. If the rate of
infection is too low, very large group sizes are required to
detect differences. If malaria exposure is too high, it may
overwhelm the vaccine or not reflect actual transmission
in endemic settings. In practice, with the small group sizes
of five to eight monkeys in malaria studies, the goal is to
use a malaria exposure which will infect all control
monkeys with high probability.
As mentioned above, there is high confidence that 100
P. knowlesi sporozoites given iv will infect a rhesus mon-
key. It is estimated that 1-2.5 sporozoites per second are
injected from the mosquito during secretion of saliva
while probing the skin [27], which may be a physical
limitation based on sporozoite diameter and mosquito
anatomy. Thus, in the minutes required for one mosquito
to probe the skin, several hundred sporozoites might leave
the mosquito, although not all of these would reach the
bloodstream. Thus, one mosquito bite should be adequate
to reliably cause a blood stage infection with P. knowlesi.
In 1968, Chin et al. [36] exposed five human volunteers
to P. knowlesi-infected Anopheles balabacencis balabacen-
cis (= Anopheles dirus) mosquitoes. The volunteers received
from one to nine infective bites. All five volunteers devel-
oped P. knowlesi infections in the blood. Thus it appeared
possible that a single bite by a P. knowlesi-infected mos-
quito might be adequate to infect a monkey. The goal of
the present study was determine the exposure to mosqui-
toes carrying P. knowlesi necessary to infect naive monkeys
with high probability.
Anopheles dirus mosquitoes require mating by hand
when grown in the laboratory, which is time-consuming.
This led us to try other mosquito species and strains
which are easier to rear. Anopheles crascens and a cross
between An. dirus and An. crascens (termed Anopheles
dirus X) were excellent hosts for P. knowlesi, and could be
reared without forced mating. Unfortunately, P. knowlesi
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found that the parasitaemia level of the donor monkey
affected the survival of infected mosquitoes and a low
donor parasitaemia produced adequate numbers of sporo-
zoites without great mosquito mortality. Methylparaben
(MPB) added to sugar solutions [37] did not consistently
reduce mortality. Finally, P. knowlesi-infected mosquitoes
were used to challenge 17 monkeys in a vaccine study,
and it was seen that increased numbers of bites led to
more rapid onset of parasitaemia.
Methods
Monkeys
The experiments described in this paper were carried
out at two facilities, the Walter Reed Army Institute of
Research/Naval Medical Research Center, Silver Spring
Maryland, USA (WRAIR/NMRC), or the Laboratory of
Malaria Immunology and Vaccinology (LMIV) and the
Laboratory of Malaria and Vector Research (LMVR),
NIAID, NIH, Rockville, Maryland, USA. Adult Macaca
mulatta bred in the US from Indian stock and maintained
in facilities accredited by the Association for Assessment
and Accreditation of Laboratory Animal Care were used
in all studies. The experiments were conducted in compli-
ance with the Animal Welfare Act and in accordance with
the principles set forth in the “Guide for the Care and Use
of Laboratory Animals,” Institute of Laboratory Animals
Resources, National Research Council, National Academy
Press, 1996. Experiments were approved by the Institu-
tional Animal Care and Use Committee, WRAIR/NMRC
or the NIAID Institutional Animal Care and Use Commit-
tee, NIH, depending on the location of the experi-
ments. M. mulatta develops higher parasitaemias than do
Macaca fascicularis and Macaca nemestrina, which are
the natural hosts of P. knowlesi. All animals with malaria
infections were closely monitored and treated with
anti-malarial drugs, and adjunctive therapy was given
as needed.
Malaria parasites
Plasmodium knowlesi H strain parasites were used in
these experiments, and were derived from stocks at NIH.
Oocysts were counted by removing the midgut of mos-
quitoes on day 7 after infection and counting under a dis-
secting microscope. Sporozoites in salivary glands were
counted by removing the glands on day 14 and estimating
the numbers of sporozoites using the following scale: 0 for
none, 1 for 1-10, 2 for 11-100, 3 for 101-1,000, 4 for
1,001-10,000, 5 for >10,000.
Monitoring and treatment of malaria infections
After sporozoite challenge, from day 6 to day 30 blood
was obtained by skin prick for thin film malaria slides.
After Giemsa-staining, blood was examined under x1,000magnification until an estimated 20,000 red cells on thin
film were examined. Infected animals were treated with
artesunate (5 mg/kg single dose) and chloroquine base
(45 mg/kg total dose divided over five days). Animals were
monitored for 30 days to ensure effectiveness of treatment
in clearing malaria infections.
Mosquitoes
Anopheles dirus (= An. dirus A=An. balabascensis bala-
bascensis ) were provided by the Malaria Research and
Reference Reagent Resource Center. Anopheles crascens
and An. dirus X (‘cross’) were provided by LMVR, NIH.
Anopheles dirus X were produced at NIH by a mating of
An. dirus males and An. crascens females. Anopheles
stephensi and Anopheles gambiae were provided by
WRAIR/NMRC.
Production of Plasmodium knowlesi infected mosquitoes
All mosquitoes were infected with P. knowlesi malaria
4-6 days after adults emerged from pupae. Prior to infec-
tion, mosquitoes were fed 10% sucrose at WRAIR/NMRC,
or 10% sucrose or 10% Karo brand syrup at NIH. Previ-
ously splenectomized monkeys were infected by iv injec-
tion of cryopreserved red blood cells infected with P.
knowlesi. Splenectomy allows repeated infections with
P. knowlesi without the animals developing immunity.
In the authors’ experience, splenectomy does not affect
gametocyte numbers or infectivity to mosquitoes. Feeding
of mosquitoes on P. knowlesi-infected monkeys was car-
ried out at 10 pm. 30-160 mosquitoes in a pint carton
were starved for eight hours prior to the feed. Feeding was
on a monkey anesthetized with ketamine and acepro-
mazine. Hair was clipped on the chest or abdomen, and
cups pressed against the skin under drapes for darkness.
After feeding for 15-30 minutes, mosquitoes not engorged
with blood were removed, and the remaining mosquitoes
were maintained at 26°C and 85% humidity. Cotton pads
soaked in sugar solution were changed daily. In some
experiments, 10% sucrose was supplemented with methyl-
paraben (MPB) beginning on the day after feeding. The
MPB solution was made by adding 1gm of MPB (Sigma-
Aldrich Corps. Louis, MO, USA) to 500 ml of a 10%
glucose solution, filter sterilizing, and storing at 4°C.
Infection of monkeys in the vaccine study by mosquito
bite challenge
Anopheles dirus X mosquitoes were used on days 14-16
after they had fed on a P. knowlesi-infected monkey.
Mosquitoes were transferred to pint cups, starved of
food and water overnight, and allowed to feed at 8 am
on the chest or abdominal skin of monkeys. Monkeys
were anesthetized with ketamine and acepromazine.
After feeding, mosquitoes were dissected to determine
the presence of P. knowlesi sporozoites in the salivary
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a measure of successful feeding. Monkeys were followed
by blood film for 30 days to determine whether they
became infected with malaria. In the preliminary studies,
containers with three to 20 mosquitoes were exposed to
each monkey for 15-30 minutes. In the vaccine challenge
study, containers with five mosquitoes were exposed
to each monkey for 15 min, in two groups of 8 and 9
monkeys.
Statistics
Exact binomial confidence intervals were used to calculate
the probability of infection after iv sporozoite injection.
For Figure 1, non-parametric maximum likelihood estima-
tors (NPMLEs) of survival were used (i.e., Kaplan-Meier
for grouped right-censored data). Because there is a high
correlation of the survival times of mosquitoes fed on the
same monkey on the same day, standard survival models
could not be used. For survival analyses on mosquitoes,
Cox frailty models were used, with frailty effects for mos-
quitoes fed on the same day on the same donor monkey.
In Table 1, Mann-Whitney U test tested for differences
between continuous variables. In Table 2, the NPMLE for
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Figure 1 Survival of heavily and lightly infected mosquitoes. Anophele
to feed on a P. knowlesi infected monkey on consecutive nights, and surviv
mosquitoes were fed. Figure 1A shows the fraction of mosquitoes surviving
P. knowlesi-infected monkey (parasitaemia of 0.2%). Figure 1B shows surviv
the parasitaemia in the P. knowlesi-infected monkey was 2.6%. Because the
between control groups by day), we used a Cox frailty model using only p
parameter for the four groups. There was a significant difference between
significant difference between the 2.6% group and the 0.2% group (p = 0.1calculated first. Then the mean of those proportions was
taken within each mosquito species and feed group. The
P-value is from the linear model with those proportions
as response, controlling for mosquito species. A Cox frailty
model with a random effect for mosquito group (a monkey
donor on a specific day) was used to estimate the inde-
pendent effects of species, experiment and donor parasit-
aemia on mosquito survival to day 15 after infection. A
Cox regression analysis was used to calculate the effect of
number of infected mosquito bites on time to first parasite
in the blood. Calculations were done in R version 3.0.1
(using the survival and interval packages) or SAS v. 9.3.
Results
Choice of mosquito species to infect with P. knowlesi
The first goal was to find a mosquito vector for P. knowlesi
that was easy to maintain. Anopheles dirus is an excellent
vector for P. knowlesi, but it requires hand mating in the
laboratory, which limits its usefulness. Efforts were fo-
cused on mosquitoes that were easy to rear. In the first
studies, an attempt was made to infect An. stephensi and
An. gambiae, which had been reported to support P.
knowlesi sporozoite development [38-41] and which were
readily available. Although these mosquitoes produced5101
 feed on donor monkeys
1510
 feed on donor monkeys
s dirus mosquitoes were put into several pint containers and allowed
al to day 15 was monitored. For each group between 140 and 160
from the first night feeds, either on an uninfected monkey or a
al of mosquitoes fed on the same two monkeys one day later, when
re was a strong day effect (logrank tests showed significant differences
arasitaemia level of the donor monkey, and with a separate frailty
the 2.6% group and the combined controls (p = 0.038), but no
8).
Table 1 Plasmodium knowlesi infections of mosquitoes fed on donor monkey on consecutive nights from Figure 1
1st night feed 2nd night feed
Monkey donor parasitaemia 0.2% 2.6%
Median number of Oocysts (interquartile range) 6.5 (2, 9.75) 80(72.5, 100) p <0.0001
Sporozoites median grade (interquartile range) 1.5 (1,2) 3 (2.25,3.75) p = 0.018
The results of dissections from the mosquitoes groups shown in Figure 1A and B. The oocyst counts are from 10 mosquitoes on day 7, and the sporozoite grading
in the salivary glands from 10 mosquitoes on day 14. The mosquitoes fed on the high parasitaemia day produced more oocysts (P < 0.0001, Mann-Whitney U test),
and sporozoites (P = 0.018, Mann-Whitney U test).
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was found in the salivary glands, and work was not con-
tinued with these species. Three types of mosquitoes pro-
duced large numbers of P. knowlesi sporozoites: An. dirus,
An. crascens, and a cross-mating of An. dirus males and
An. crascens females termed An. dirus X (‘cross’). Both An.
crascens and An. dirus X mosquitoes mate well in the
laboratory and were more easily produced in large
numbers than An. dirus.
Survival of P. knowlesi-infected mosquitoes of An.
dirus, An. dirus X, and An. crascens were compared in
five experiments at high and low donor parasitaemia. In
monkeys, P. knowlesi parasitaemia increases 10-fold every
day, so groups of mosquitoes fed on the same monkey on
consecutive nights provided the low and high parasite
groups. In some experiments mosquitoes were fed on an
uninfected monkey as a control. Figure 1 and Table 1
show representative data from one of the experiments.
Mosquitoes feeding on donor monkeys with a high
parasitaemia had large numbers of oocysts in the midgut
dissections on day 7, high levels of sporozoites on gland
dissections on day 14, but poor survival. Mosquitoes fed
on the same donor monkeys a day earlier when the para-
sitaemia was lower, had smaller numbers of oocysts and
sporozoites, and better survival. This was true for An.
dirus, An. dirus X, and An. crascens mosquitoes. Overall,
16 groups of mosquitoes were fed on monkeys with a
parasitaemia greater than 2%, and the median of the day
14 survival was 32% (interquartile range [IQR]: 23%,
38%). All three types of mosquitoes produced largeTable 2 The effect on survival of adding methyparaben to mo
Exp 1a Exp 1b Exp
Mosquito species dirus X dirus
Mosquito age at feed 5 days 8 days 5 day
Monkey donor parasitaemia 12% 12% 1.30%
% surviving fed sugar only (# replicate cups) 53% (4) 88% (4) 87% (
% surviving fed sugar + MPB (# replicate cups) 91% (6) 45% (2) 81% (1
p < 0.001 p = 0.04 p = 0.
Methylparaben (MPB) was added to the sugar solution used for feeding mosquitoe
same batch were maintained on sugar solution without MPB. Experiments 1, 2 and
donor monkey. In some experiments, there were several replicate cups of mosquito
Percentage surviving is the mean from each cup to day 14. P-values were calculate
and no statistical test could be done. MPB only improved survival in one of nine sunumbers of P. knowlesi sporozoites (see Additional file 1
for complete data). Survival data from the five experi-
ments were analysed using a Cox Frailty model. Higher
donor parasitaemia was significantly associated with
lower mosquito survival (p-value <0.001) after correcting
for mosquito species effects and experiment effects.
Methylparaben as an additive to improve mosquito survival
Methylparaben (MPB) is an antibacterial and antifungal
agent which can improve the survival of malaria-infected
mosquitoes when maintenance sugar solutions are chan-
ged infrequently [37]. The addition of MPB to the sugar
solution was tested in our laboratories where sugar pads
are changed daily. Three experiments were done adding
MPB at 2 gm/L to the sugar solutions of some mosqui-
toes while others received standard sugar solution.
Table 2 shows the effect of MPB on the percentage of
mosquitoes surviving to day 14 after P. knowlesi infec-
tion. In Experiment 1a using mosquitoes aged 5 days at
feed, MBP enhanced survival. In Experiment 1b using
mosquitoes aged 8 days at feed there was a significant
worsening of survival (p = 0.04). In Experiment 2, there
was no significant difference in survival. Experiment 3
had six subgroups of mosquitoes fed on monkeys with
5.5%, 0.3% or no malaria infection. In all the subgroups
of Experiment 3, MPB decreased the fraction of mosqui-
toes surviving until day 14, but the difference was sig-
nificant only in the mosquitoes fed on the donor
monkey with 5.5% parasitaemia. Overall, the effects of
MPB on survival were inconsistent.squito feed
2 Exp 3a Exp 3b Exp 3c Exp 3d Exp 3e Exp 3f
X crascens dirus dirus X dirus dirus dirus X
s 5 days 5 days 5 days 5 days 5 days 5 days
5.50% 5.50% 5.50% 0.30% 0% (control) 0% (control)
4) 36% (1) 41% (2) 22% (1) 64% (1) 88% (1) 24% (1)
4) 20% (1) 29% (2) 0% (1) 41% (1) 49% (1) 2% (1)
15 p = .03 NA p = .18
s starting the day they were infected with P. knowlesi. Mosquitoes from the
3 were on different dates, and have been subdivided by mosquito species and
es for each feeding group. Sugar solutions on cages were changed daily.
d as described in Methods section. For experiment 3d, there were only 2 cups
b-experiments.
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required to transmit malaria to a monkey?
Over several years, 49 monkeys were exposed to varying
numbers of mosquitoes (3 to 20) for 15 to 30 min. Im-
mediately after, mosquitoes were dissected to determine
the numbers of sporozoites in the salivary glands and
the presence of ingested blood as a mark of successful
feeding. Monkeys were followed for 30 days to deter-
mine if parasitaemia developed. The results of mosquito
dissections and monkey infections are summarized in
Table 3 (see Additional file 2 for complete data). Exposures
were placed into Categories A, B, C or D of decreasing in-
tensity. Category A exposures were the most intense, with
two or more dissected mosquitoes having both P. knowlesi
sporozoites and ingested blood as a sign they had probed
and injected sporozoites. Nine exposures were in Category
A, and all led to P. knowlesi infections in the monkeys.
Category B exposures had only one mosquito with both
sporozoites and ingested blood. Eight exposures were
in Category B and all eight led to monkey infections.
Category C exposures were those where one or more
mosquitoes carried P. knowlesi sporozoites, even though it
had not ingested blood. Ten exposures were in Category
C, and 4 of these led to infected monkeys. Finally, Cat-
egory D exposures were those where upon dissection no
mosquitoes were found to carry P. knowlesi sporozoites.
22 exposures were in Category D, and 1 of these monkeys
developed a P. knowlesi infection.
Category B exposures show that even a single P. know-
lesi-infected mosquito feeding is enough to transmit mal-
aria to a non-immune monkey. Of the eight mosquitoes
positive for both sporozoites and ingested blood in Cat-
egory B, five had only grade 2 sporozoites (11-100) in the
salivary gland dissections (the remaining three mosquitoes
had P. knowlesi sporozoites but were not quantitated).
The results from Category C exposures were even moreTable 3 Summary of exposure to P. knowlesi-infected













A ≥ 2 0 to 10 9 100
B 1 0 to 8 8 100
C 0 ≥ 1 10 40
D 0 0 22 4
From 3-20 mosquitoes infected with P. knowlesi were exposed to a monkey for
15-30 minutes on 49 occasions. Mosquitoes were dissected to grade the
sporozoites in the salivary glands, and identify ingested blood in the mosquito
midgut. Monkeys were followed for 30 days to see if they developed parasites
in the blood. Category A exposures had two or more mosquitoes containing
both sporozoites and blood. Category B exposures had only one mosquito
with both sporozoites and blood. Category C exposures had some mosquitoes
with sporozoites but none of these had ingested blood. Category D exposures
had no mosquitoes with any sporozoites in the salivary glands, nor any
mosquitoes with ingested blood.surprising. Mosquitoes inject sporozoites while they
are probing the skin looking for a blood vessel. Monkey
infections from Category C exposures occurred without
mosquitoes having ingested blood, so presumably the spo-
rozoites which initiated these infections were transmitted
to the monkey during probing which did not result in
blood feeding. That 40% of these exposures led to monkey
infections shows that successful feeding is not required for
transmission of P. knowlesi. In theory, Category D expo-
sures should not have resulted in any monkey infections,
but one of 22 monkeys became infected. It is probable that
the mosquito dissections missed a very small number of
sporozoites or that all sporozoites were injected into
the monkey during feeding. Overall, we conclude that
P. knowlesi can be transmitted to monkeys extremely effi-
ciently by P. knowlesi-infected mosquitoes. Feeding by a
single infected mosquito carrying only modest numbers of
sporozoites consistently transmitted malaria to monkeys.
Feeding rates of mosquitoes at day 0 and day 14
To produce P. knowlesi sporozoites, mosquitoes were
used 4-6 days after they emerged from pupae to adult.
On the day of feeding, it was usual to have 95% of these
young mosquitoes take a blood meal. Unfed mosquitoes
were then removed and the mosquitoes kept for 14 days
while oocysts and then sporozoites developed. Mosqui-
toes were used to infect monkeys by bite on day 14-16.
Blood feeding rates for these older P. knowlesi-infected
mosquitoes was near 50% but ranged from 10 to 90%.
Using P. knowlesi-infected mosquitoes in a malaria vaccine
challenge in monkeys
Based on experience outlined in Table 3, a mosquito bite
challenge was planned to test a monkey malaria vaccine
based on the P. knowlesi sporozoite circumsporozoite pro-
tein. Details of the study are being published elsewhere. In
this paper, technical aspects of the malaria challenge
by exposure to P. knowlesi-infected mosquitoes will be
discussed.
Seventeen monkeys were challenged with malaria by
mosquito exposure. Six monkeys had received a control
vaccine and 11 had received malaria vaccine. It was de-
cided to aim for an exposure that would result in blood
ingestion by at least two mosquitoes carrying P. knowlesi
sporozoites. Each monkey was exposed to five An. dirus
mosquitoes for 15 minutes as described in the methods
section. Results are shown in Table 4.
The 17 monkeys were challenged in random order but
are listed in Table 4 by vaccine group for clarity. After
feeding, when the mosquitoes were dissected, from 2 to 5
carried both sporozoites and ingested blood in containers
from each of the 17 monkeys. Of the 85 mosquitoes in the
challenge, 62 were found to have ingested blood for a bite
Table 4 Results of a mosquito bite challenge in 17 rhesus
monkeys












1 Control 2 4,4 9
2 Control 3 4,4,4 8
3 Control 3 4,4,4 8
4 Control 4 4,4,4,4 8
5 Control 4 4,4,4,4 7
6 Control 4 2,4,4,4 9
7 Vaccine 2 4,4 7
8 Vaccine 3 4,4,4 7
9 Vaccine 3 4,4,4 9
10 Vaccine 3 2,4,4 8
11 Vaccine 4 2,3,4,4 8
12 Vaccine 4 4,4,4,4 9
13 Vaccine 4 4,4,4,4 7
14 Vaccine 4 3,4,4,4 7
15 Vaccine 5 4,4,4,4,4 9
16 Vaccine 5 2,4,4,4,4 7
17 Vaccine 5 4,4,4,4,4 7
17 rhesus monkeys were exposed to five P. knowlesi infected mosquitoes for
15 minutes, in two groups of 8 and 9 monkeys each. The six control monkeys
and 11 monkeys receiving malaria vaccine were challenged in random order,
but are shown by group for ease of analysis. Mosquitoes were dissected to
determine sporozoite grade in the salivary glands and the presence of
ingested blood. All 17 monkeys developed parasites in the blood, and the first
day parasites were detected is recorded.
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parasites in the blood on day 7 to 9 after exposure.
There was no significant difference in time to first parasit-
aemia in control versus vaccinated monkeys (Logrank test,
p = 0.46).
Does feeding by larger numbers of infected mosquitoes
lead to more rapid onset of parasitaemia?
When sporozoites are injected by mosquito, they travel
quickly to the liver, and begin to develop inside hepa-
tocytes. Hepatocyte development averages 4.5 days for
P. knowlesi [1], after which thousands of merozoites
from each hepatocyte enter the blood and infect red
blood cells. In theory, monkeys with few infected hepato-
cytes will have lower numbers of merozoites entering the
blood than monkeys with large numbers of infected hepa-
tocytes. Since a constant number of red blood cells on
each slide is examined, the injection of larger numbers of
sporozoites would be expected to lead to earlier detection
of parasites.
The number of infected mosquito bites correlated with
the time when parasites were first detected in the blood.
Of the 49 infections of non-immune monkeys, 13 hadcomplete data on both number of infected mosquito
bites and day of first parasitaemia. Combining these 13
with the 17 monkeys from vaccine challenge, and using
Cox regression, effects of experiment and number of
mosquito bites on time to first detection were examined.
As there was no significant effect of experiment, a simpler
Cox model was used with only number of mosquito bites
as a predictor. Figure 2 shows a graph of these data. Each
additional bite increased the hazard by a factor of 1.41
(95% CI: 1.08, 1.82). As it was possible that the monkey
receiving 10 mosquito bites was driving the results, the
analysis was repeated without this data point but the
results were similar (HR = 1.28, 95% CI: 0.95, 1.73). The
authors conclude that increasing numbers of infected
mosquito bites lead to earlier detection of P. knowlesi in
the blood.
Discussion
Survival of P. knowlesi-infected mosquitoes
The aim of these studies was to learn how to challenge
monkeys with the bite of P. knowlesi-infected mosquitoes
for vaccine studies. However, the first problem was to
produce enough P. knowlesi-infected mosquitoes that
survived until sporozoites appeared in the salivary
glands. The high death rate of P. knowlesi-infected mos-
quitoes was something of a surprise. In the 1960’s and
1970’s, An. dirus sensu lato produced large numbers
of P. knowlesi sporozoites without excessive losses of in-
fected mosquitoes (Robert Gwadz, personal communi-
cation). These mosquitoes often carried several hundred
oocysts, and dissections of salivary glands yielded up to
250,000 P. knowlesi sporozoites per mosquito. Why are
the current death rates of the infected mosquitoes so high?
It is possible that the current P. knowlesi and mosquito
strains available are different from those used 40 years
ago. However, this history gave hope that we could pro-
duce the numbers of P. knowlesi-infected mosquitoes re-
quired for vaccine studies.
Mosquitoes fed on monkeys with a high parasitaemia
developed large numbers of oocysts, but had high death
rates during the second week, so that by 14 days after
the feed there were sometimes only 10% of mosquitoes
surviving. Control groups which were fed on uninfected
monkeys or on monkeys with a lower parasitaemia typic-
ally had survival of greater than 70%. This difference in
mortality between heavily and lightly infected mosqui-
toes happened in all the species and strains of mosqui-
toes we tested. It also occurred in both insectaries used
for these studies, the one at WRAIR/NMRC in Silver
Spring MD, and the other at NIH in Rockville MD. It is
not understood what is causing the death of heavily
infected mosquitoes. One possibility is that there is
something toxic in the blood of monkeys that have high
levels of P. knowlesi infection, such as a cytokine [42],
Figure 2 Effect of number of infected mosquitoes feeding on day parasites detected in blood. Thirty monkeys were infected with
P. knowlesi by the bite of from 1 to 10 mosquitoes which had sporozoites in the salivary glands and had ingested blood. The day on which the
first P. knowlesi parasites were found in the blood is plotted against the number of infectious bites. Increasing numbers of bites lead to earlier
detection of parasites in the blood. Cox regression analysis shows the number of infected mosquito bites increased the hazard of parasites
appearing in the blood (p = 0.01).
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toxic substance was ingested, mosquito mortality might
be expected to be highest soon after they fed on an
infected monkey. However, the excess mosquito deaths
happened after the first week of oocyst development, so it
is not likely that a toxin from the monkeys is responsible
for killing mosquitoes.
The large numbers of P. knowlesi oocysts may be
contributing to mosquito death, but it seems less likely
that the large numbers of sporozoites are harmful to the
mosquitoes. Mortality in P. knowlesi-infected mosquitoes
typically is not high during the first week, but increases
8-12 days after the feed on the infected monkey. During
these days, oocysts are large in size but sporozoites have
just begun to emerge into the haemolymph and enter
the salivary glands. Mortality and stress from oocysts is
supported by the results of the one experiment that
included An. stephensi. Plasmodium knowlesi infection
produced large numbers of oocysts in An. stephensi, but no
sporozoites in the salivary glands. However, An. stephensi
mosquitos fed on a control uninfected monkey had a sur-
vival rate to day 15 of 41.6% while mosquitos feeding on a
monkey with 2.6% P. knowlesi infection had only a 15.4%
survival rate (p < 0.001, Cox frailty model). Although this
is data from a single experiment, it supports the theory that
the excess mortality to is due to oocysts, not sporozoites.
This is not the first example of intense malaria infections
increasing mortality in An. dirus mosquitoes. In 1986,
Klein et al. [43] reported that when An. dirus were infected
with Plasmodium cynomolgi, there was excess mortality in
the infected groups. This mortality was only seen in mos-
quito groups with greater than 10 oocysts. Survival rates in
all groups were similar during the first week, and onlyincreased in the heavily infected mosquitoes beginning
after the first 8 days of incubation. These results with
P. cynomolgi infection exactly parallel the results with
P. knowlesi infections of mosquitoes.
Other studies have looked at the role of malaria in-
fection in mosquito survival. In a 2002 meta-analysis,
Ferguson and Read [44] showed that although half of
the studies reported no effect of Plasmodium on survival,
the other half reported shorter lifespans in infected mos-
quitoes. The negative effects of Plasmodium on survival
were more likely to appear in non-natural mosquito–para-
site combinations, but the authors were unsure of the
cause of the discrepant results.
Both An. dirus and An. crascens have been found
infected with P. knowlesi in the wild [45,46]. While they
may not always be the primary vectors carrying P. knowlesi,
it seems unlikely that the high mortality seen in this study
is due to an artificial pairing of mosquito and parasite.
Two recent studies have looked at mortality in malaria-
infected mosquitoes subjected to additional stress. Aboagye-
Antwi et al. [47] caught An. gambiae in Mali and studied
survival of mosquitoes with or without naturally occurring
P. falciparum infections. They found that when water was
provided, there was little difference in mortality between
mosquitoes carrying malaria oocysts and uninfected mos-
quitoes. However, when water was withheld, the mos-
quitoes with oocysts died faster than the uninfected
mosquitoes. Mosquitoes carrying sporozoites had the
same survival as the uninfected mosquitoes.
In 2012, Vezilier et al. [48] investigated the role of egg-
laying on the mortality of malaria-infected mosquitoes.
Using a naturally occurring mosquito-parasite pair, they
found no difference in survival between infected and
Murphy et al. Malaria Journal 2014, 13:215 Page 9 of 11
http://www.malariajournal.com/content/13/1/215uninfected groups when mosquitoes were not allowed to
lay eggs. However, when egg-laying was allowed, infected
mosquitoes laid fewer eggs but lived longer than the unin-
fected controls. They surmised that the parasite redirects
the mosquitoes’energy away from egg laying into prolong-
ing life. This highlights the complex parasite-host interac-
tions which may affect mosquito survival.
Excess mortality in heavy P. knowlesi infections might
be due to a stress on the mosquito midgut from the large
number of P. knowlesi oocysts. This stress may peak
around day 7 when oocysts reach their full size. Stress
from oocysts may combine with other stresses that were
not measured, such as bacterial or fungal infection, or
sub-optimal culture conditions.
Infectivity of mosquitoes carrying P. knowlesi
Data on the high infectivity of P. knowlesi-carrying mos-
quitoes is consistent with the early observations of Chin
et al. [36], who found that a bite from a single infected
mosquito was able to infect the one human volunteer
tested. In our hands, a single exposure to a mosquito car-
rying P. knowlesi sporozoites caused a malaria infection in
8/8 attempts. Most of these infections by single bite were
from mosquitoes with only 11-100 sporozoites in their
salivary glands. This indicates that the P. knowlesi sporo-
zoites from lightly infected mosquitoes are quite virulent.
The data show that 4/10 monkeys exposed to P. knowlesi-
infected mosquitoes developed malaria in the absence of a
detected blood meal. This means that measurements of
exposures to P. knowlesi malaria should not be limited to
counting mosquitoes with both blood meals and spo-
rozoites, as this may underestimate the true sporozoite
inoculum.
Chin et al. [36] noted a dose response effect in their
five human subjects, with more infected bites leading to
earlier detection of parasites in the blood. The data in 30
monkeys confirm this finding. Our interpretation is that
fewer infective bites lead to fewer sporozoites reaching
the liver and fewer liver-stage schizonts. This translates
into fewer merozoites released from the liver, and a longer
time until parasites are first detected in the blood. Any-
thing that reduces the number of sporozoites reaching the
liver should have the same effect. Therefore, delay to first
parasitaemia is a valuable way to evaluate partial efficacy
of vaccines directed at P. knowlesi pre-erythrocytic stages.
A P. knowlesi mosquito bite challenge was used here in
a monkey vaccine trial. 17 monkeys, six control and 11
vaccinated animals, were exposed to five P. knowlesi-in-
fected mosquitoes for 15 minutes. The vaccine did not
protect any of the monkeys, and all the control and vacci-
nated monkeys developed malaria parasites in their blood
7 to 9 days after exposure. Although the preliminary data
suggested that a single bite from a P. knowlesi-infected
mosquito was adequate exposure to infect controls, it wasdecided to aim for at least two infected bites for each ani-
mal. Two bites were chosen instead of one, as with data
from only eight animals there was not great confidence
that a single bite would always transmit malaria. This
study was also influenced by data from murine malaria,
where a single bite from an infected mosquito only pro-
duced malaria infection in 39% of mice [29]. By estimating
that 90% of the batch of mosquitoes was carrying P. know-
lesi sporozoites, and estimating that 50% of mosquitoes
would succeed in taking a blood meal, it was calculated
(using binomial probabilities) that exposing each monkey
to five mosquitoes would deliver at least two infective
bites to each animal with probability of about 75%. In
retrospect, exposing each monkey to fewer infective
mosquitoes (perhaps 3 or 4) would have provided at
least one infective bite which would have been an adequate
challenge. With more experience in vaccine challenges by
mosquito bite using P. knowlesi, the authors hope to gener-
ate the data to answer this question.
Plasmodium knowlesi sporozoites in rhesus seem to be
more infectious than Plasmodium falciparum sporozo-
ites in humans. While the data show that one infective
bite is probably adequate to infect a monkey, human
studies have shown that volunteers exposed to two bites
of P. falciparum-infected mosquitoes do not always
become infected [49,50]. This has led to the standard of
five bites by P. falciparum-infected mosquitoes for labora-
tory-based malaria vaccine trials [51]. The reasons for
this difference in virulence between P. knowlesi and
P. falciparum are not understood. In the wild, most
human infections by P falciparum and P. knowlesi are
probably both caused by a single bite by a Plasmodium-
carrying mosquito.
Adding methylparaben to the sugar water of infected
mosquitoes did not improve survival. The original paper
describing methylparaben [37] in mosquitoes carrying
Plasmodia indicated that survival benefits were not evi-
dent when sugar pads were changed daily. As sugar pads
were changed every day in our insectaries, the failure to
see improvement was not surprising.
Conclusions
Mosquitoes fed on donor monkeys with a high P. knowlesi
parasitaemia have poor survival. Lower donor parasi-
taemias allow better mosquito survival and adequate
sporozoite production. Plasmodium knowlesi-infected
mosquitoes are extremely infectious, and a single bite
is able to infect a monkey. Based on these results, a
plan has been formulated for future P. knowlesi challenges
of malaria vaccines by mosquito bite: (1) Anopheles cras-
cens or An. dirus X mosquitoes will be used; (2) mosqui-
toes will be fed on a donor monkey when parasitaemia is
from 0.2 to 2.0%; and (3) the goal of exposure will be one
mosquito having both P. knowlesi sporozoites in the
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in the midgut. To achieve this single infectious bite, chal-
lenge will start with one exposure to mosquitoes, with a
second exposure if necessary. For the first exposure, the
number of infective P. knowlesi mosquitoes exposed to
each monkey will be calculated from dissection of 10 mos-
quitoes to estimate the percentage having at least grade 2
(11-100) sporozoites in the salivary glands, and assuming
a 50% bite rate. (For example, if 100% of mosquitoes are
carrying P. knowlesi sporozoites, each monkey would be
exposed to two mosquitoes.) All monkeys will receive this
exposure for 15-30 minutes to allow as many mosquitoes
to take a blood meal as possible. After exposure, all
mosquitoes will be dissected to determine the number
of mosquitoes carrying P. knowlesi sporozoites that
ingested blood from each monkey and the actual bite
rate will be calculated. If any animals have not received
one infective bite in the first exposure, these monkeys will
be exposed to P. knowlesi-infected mosquitoes from the
same batch a second time. The second exposure may be
on the same day as the first exposure or the day following,
the timing depending on the ability of the monkeys to
tolerate anesthesia. The number of mosquitoes used for
the second exposure will be calculated using the rate of
sporozoite infection and the actual bite rate from the first
exposure.
Additional files
Additional file 1: Experiments 1 to 5 of mosquito survival after
P. knowlesi infection. Description of data: This spreadsheet provides the
mosquito species, donor monkey parasitaemia, total number of
mosquitoes alive, and the oocyst and sporozoite dissection results for five
separate experiments.
Additional file 2: Monkey infections after exposures to P. knowlesi
infected mosquitoes. Description of data: This spreadsheet provides the
infection results of 49 monkey exposures to P. knowlesi infected
mosquitoes, as well as the data from the mosquito dissections.
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